Contour Neurovascular System for Brain Aneurysm
(NECC Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does mention that if you are on anticoagulation medications (like warfarin) that cannot be stopped, you may not be eligible to participate.
Is the Contour Neurovascular System safe for treating brain aneurysms?
How is the Contour Neurovascular System treatment different from other treatments for brain aneurysms?
The Contour Neurovascular System is unique because it treats brain aneurysms by disrupting blood flow within the aneurysm itself, rather than using traditional methods like coils or stents. This approach is particularly useful for wide-necked aneurysms, which are challenging to treat with other devices.12467
Research Team
Pascal M Jabbour, MD
Principal Investigator
Jefferson University Hospitals
Demetrius Lopes, MD
Principal Investigator
Advocate Medical Group - Brain and Spine Institute
Eligibility Criteria
This trial is for adults aged 18-75 with certain wide-necked brain aneurysms sized between 2 and 10.5 mm that require repair, who can follow the study schedule. Excluded are those on non-stop anticoagulants, with severe kidney issues not on dialysis, pregnant or breastfeeding women, participants in other conflicting studies, individuals allergic to device materials or contrast dye, and those with conditions affecting study compliance.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Contour NEurovasCular System™ for the treatment of wide-necked bifurcated saccular, intracranial aneurysms
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Contour NEurovasCular System™
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cerus Endovascular, Inc.
Lead Sponsor
Cerus Endovascular, Ltd
Lead Sponsor